# A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

> **NCT07222969** · PHASE1,PHASE2 · RECRUITING · sponsor: **Vibrant Sciences Limited** · enrollment: 146 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** VIB305 for Injection

## Key facts

- **NCT ID:** NCT07222969
- **Lead sponsor:** Vibrant Sciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-12
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222969, "A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07222969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*